Medicover Integrated Clinical Services Sp. z o.o. — Clinical Trial Site

214 Registered trials

88 Currently recruiting

Organisation

Medicover Integrated Clinical Services Sp. z o.o.

Location

Torun, Poland

Identifier

ORG-100042794

Address

Ul. Stefana Batorego 18/22, 87-100, Poland

Departments

-
(MICS) Centrum Medyczne Bydgoszcz
#2306 - Reumatologia
#3000: Rheumatology
#3205 - N/A
#3205:Centrum Medyczne Bydgoszcz
#3206 - N/A
#3206:Centrum Medyczne Warszawa
#40040: MICS Centrum Medyczne Torun
#40097: nap
#40097: Reumatology
#40097: Rheumatology
#409: MICS Centrum Medyczne Warszawa
#416: MICS Centrum Medyczne Torun
#7003; MICS Centrum Medyczne Torun
#7004; MICS Centrum Medyczne Warszawa, Chlodna
#7806: Rheumatology
1802 : Centrum Medyczne Warszawa
2704: MICS Centrum Medyczne Toruń
2801 : NA
2902: Reumatologia
2903: Reumatologia
3000:Cardiology
301-151: MICS Centrum Medyczne Bydgoszcz
3041
3554: NA
3554: Reumatologia
405_MICS Centrum Medyczne Warszawa
40788: Dermatology
40788: MICS Centrum Medyczne Toruń
40793: MICS Centrum Medyczne Warszawa
40798: MICS Centrum Medyczne Bydgoszcz
8503:MICS Centrum Medyczne Bydgoszcz
Cardiology
cardiology department
Centrum Medyczne Bydgoszcz
Centrum Medyczne Toruń
Centrum Medyczne Warszawa
Chronic pain
Dermatology
Dermatology and Venereology
Dermatology Department
Hematology Department
Klinika Kardiologii
Medicover Integrated Clinical Services
Medicover Integrated Clinical Services Sp. z o.o.
MICS
MICS Centrum Medyczne Warszawa
MICS Centrum Medyczne Warszawa
MICS Centrum Medyczne Bydgoszcz
MICS Centrum Medyczne Bydgoszcz
MICS Centrum Medyczne Bydgoszcz ul. Chodkiewicza 19C, 85-065 Bydgoszcz is the site name
MICS Centrum Medyczne Szczecin
MICS Centrum Medyczne Torun
MICS Centrum Medyczne Warszawa
MICS Centrum Medyczne Warszawa Chłodna
MICS Centrum Medyczne Warszawa, Chłodna
MICS Centrum Medyczne Warszawa, ul. Wronia 53 lok.B10, 00-874 Warszawa- is the site name
MICS Centum Medyczne Warszawa
MICS Medical Center Warsaw
Miejsce prowadzenia badania: MICS Centrum Medyczne Bydgoszcz
MISC Centrum Medyczne Warszawa
N/A
N/D
NA
No Department
Not applicable
not applicable/nie dotyczy
Oncology
Outpatient Clinic
PL10008: Rheumatology
PL10013: Rheumatology
PL10026: Rheumatology
POL03295: Dermatology
Private Hospital
reumathology
Rheumatology
Site name: MICS Centrum Medyczne Bydgoszcz
Site name:MICS Centrum Medyczne Toruń,

Clinical trials at this site (214)

Search interface

Phase 3, Placebo-Controlled, Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Trial of a 6-Valent OspA-Based Lyme Disease… Ended

2023-509105-72-00 Active immunization against Lyme disease 5 2022-08-10
A study comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF5993 With the Fixed Dose Dual Combination CHF153… Ended

2023-510172-31-00 Chronic obstructive pulmonary disease (COPD) 5 2022-04-22
MENACWY=MEN7B-003 Ended

2023-506449-40-00 Infections, Meningococcal 9 2021-11-29
A Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients with Diffuse Cutaneous Systemic Sclerosis Ended

2023-509782-20-00 Diffuse Cutaneous Systemic Sclerosis 4 2021-11-11
Study of efficacy, safety, and tolerability of LNA043 in patients with symptomatic knee osteoarthritis Ended

2023-509937-37-00 Osteoarthritis 4 2021-07-21
The efficacy and safety of two doses of CHF6001 DPI as add-on to maintenance COPD triple therapy Ended

2023-510174-13-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2021-06-17
The efficacy and the safety of two doses of CHF6001 for the treatment of Chronic Obstructive Pulmonary Disease (COPD) Ended

2023-510175-60-00 Chronic obstructive pulmonary disease (COPD) and Chron 5 2021-06-16
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Tildrakizumab in Anti-TNF Experien… Ended

2023-507415-35-00 Psoriatic Arthritis 5 2021-01-15
Phase I/II, First in Human, Dose Escalation Trial of TL-895 Monotherapy in Subjects with Relapsed/Refractory B-Cell Malignancies and Expansi… Ended

2024-516691-14-00 B Cell Malignancies and Chronic Lymphocytic Leukemia or 7 2021-01-05
Double-blind (neither the patient nor the doctor knows treatment allocation of the patient), randomized, placebo-controlled, prospective pha… Ended

2023-509737-39-00 Primary infection prophylaxis in patients with chronic 5 2020-08-19
An extension study to learn if Bimekizumab works and is safe over a long period in adults with Active Axial Spondyloarthritis. Ended

2023-506527-28-00 Axial Spondyloarthritis 5 2020-06-29
Phase 3 Study of Pembrolizumab/Placebo plus Enzalutamide plus ADT in mHSPC Ended

2023-507024-24-00 Metastatic hormone sensitive prostate cancer 5 2020-05-05
Evaluation of upadacitinib in adult subjects with axial spondyloarthritis Ended

2022-501018-78-00 Axial Spondyloarthritis 5 2020-03-23
An Open-Label, Multi-Center Extension Study to Characterize the Long-Term Safety and Efficacy of BMS-986165 in Subjects with Moderate-to-Sev… Ended

2022-502361-15-00 Moderate-to-Severe Plaque Psoriasis 5 2019-12-12
A study to learn if Bimekizumab is safe and works over a long period in adults with Active Psoriatic Arthritis Ended

2023-506528-95-00 Psoriatic Arthritis 5 2019-11-21
A Phase I, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Patients with Re… Ended

2024-515123-11-00 Lymphoma 3 2019-09-05
Phase 3b/4 Study in Rheumatoid Arthritis Ended

2023-508022-10-00 Rheumatoid Arthritis 6 2019-07-25
A Randomized, Double-blind, Parallel-group, Active-controlled Study to Compare the Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and… Ended

2024-512417-41-00 Osteoporosis 5
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of Abiprubart i… Ended

2024-512986-15-00 Sjögren’s Disease 4
CHRONOS - A study to learn about the effects and safety of ODM-111 in participants with long-lasting pain due to osteoarthritis of the knee. Ended

2024-513553-79-00 Chronic Pain due to Ostheoarthritis of the knee 4
CHRONDI Ended

2024-513595-17-00 CHRONIC PAIN DUE TO DIABETIC PERIPHERAL NEUROPATHY 4
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain ( TRIUMPH-7 ) Ended

2024-517431-43-00 Overweight 5